Qilu Pharma Inc
General
Total Cases27
Active Cases6
Patents10
Ratings
Experience
Grade
Trend
DCT
L1
E
PTAB
--
--
--
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 08/06/24 | PAPER #4 MAILED TO PATENT OFFICE (JL) (Entered: 08/06/2024) | |
| 08/05/24 | REPORT on the filing or determination of an action. MAILED TO THE U.S. PATENT AND TRADEMARK OFFICE. (bw) (Entered: 08/05/2024) | |
| 08/05/24 | Summons Issued as to QILU PHARMA, INC., QILU PHARMACEUTICAL CO., LTD.. E-MAILED To: COUNSEL on 8/5/24 (bw) (Entered: 08/05/2024) | |
| 08/02/24 | SUMMONS ISSUED as to QILU PHARMA, INC., QILU PHARMACEUTICAL (HAINAN) CO., LTD.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (jdg, ) (Entered: 08/02/2024) | |
| 08/02/24 | AO120 Patent/Trademark Form filed. (jdg) (Entered: 08/02/2024) | |
| 08/02/24 | Disclosure Statement Form pursuant to FRCP 7.1 by ASTELLAS PHARMA INC., ASTELLAS PHARMA US, INC., ASTELLAS US LLC, MEDIVATION LLC, MEDIVATION PROSTATE THERAPEUTICS LLC, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA.(BROWN, DANIEL) (Entered: 08/02/2024) | |
| 08/02/24 | Magistrate Judge Rukhsanah L. Singh added. (jdg, ) (Entered: 08/02/2024) | |
| 08/02/24 | COMPLAINT against All Defendants ( Filing fee $ 405 receipt number APAEDC-17647622.), filed by THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, ASTELLAS US LLC, MEDIVATION LLC, MEDIVATION PROSTATE THERAPEUTICS LLC, ASTELLAS PHARMA INC., ASTELLAS PHARMA US, INC.. (Attachments: # 1 Civil Cover Sheet, # 2 Designation Form, # 3 Supplement, # 4 Supplement, # 5 Exhibit Exhibit A, # 6 Exhibit Exhibit B)(BROWN, DANIEL) (Entered: 08/02/2024) | |
| 08/02/24 | COMPLAINT against All Defendants ( Filing fee $ 405 receipt number APAEDC-17647622.), filed by THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, ASTELLAS US LLC, MEDIVATION LLC, MEDIVATION PROSTATE THERAPEUTICS LLC, ASTELLAS PHARMA INC., ASTELLAS PHARMA US, INC.. (Attachments: # 1 Civil Cover Sheet, # 2 Designation Form, # 3 Supplement, # 4 Supplement, # 5 Exhibit Exhibit A, # 6 Exhibit Exhibit B)(BROWN, DANIEL) (Entered: 08/02/2024) | |
| 08/01/24 | Corporate Disclosure Statement by ASTELLAS PHARMA INC., ASTELLAS PHARMA US, INC., ASTELLAS US LLC, MEDIVATION LLC, MEDIVATION PROSTATE THERAPEUTICS LLC, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA. (WALSH, LIZA) (Entered: 08/01/2024) |